Track topics on Twitter Track topics that are important to you
VANCOUVER, Nov. 29, 2018 /PRNewswire/ - BlueBird Battery Metals Inc. (TSXV: BATT; US: BBBMF) (the "Company" or "BlueBird") is pleased to announce results from the Read more...
Bluebird Bio opened a manufacturing facility in Durham, N.C., to produce lentiviral vectors for its gene and cell therapies, -More-
The European Commission (EC) has granted conditional marketing authorisation to bluebird bio’s gene therapy Zynteglo for the treatment of transfusion-dependent...Read More... The post EC grants cond...
A nod from an EMA expert panel means Bluebird's LentiGlobin for beta-thalassemia has just one last hurdle before it's cleared.
Bluebird Bio won’t be selling the world’s most expensive drug. The second priciest? Yup.
Andrew Obenshain, senior vice president and head of Europe at bluebird bio, introduces the company and discusses the challenges and opportunities of gene therapy
The German CDMO will operate as commercial manufacturer in Europe for Zynteglo, bluebird bio's first gene therapy to gain regulatory approval
NEW YORK, Dec. 5, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE). Such investors are advised t...
A total of 50 poultry farms of commercial broilers (N = 39) and commercial layers (N = 11) suffered from respiratory problems and mortality during the period from January 2016 to December 2017 were in...
This is a multi-center, long-term safety and efficacy follow-up study for subjects with hemoglobinopathies (β-thalassemia or severe sickle cell disease) who have been treated with ex vivo...
bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting
bluebird bioÂ is developing innovative gene therapies for severe genetic disorders.Â At the heart of bluebird bioâs product creation efforts is its broadly applicable gen...
The REVOLUTION Medicines team brings deep expertise and a track record of building exceptional life sciences companies. In addition to Dr. Goldsmith, founding president and...
We have published hundreds of bluebird bio, Inc. news stories on BioPortfolio along with dozens of bluebird bio, Inc. Clinical Trials and PubMed Articles about bluebird bio, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of bluebird bio, Inc. Companies in our database. You can also find out about relevant bluebird bio, Inc. Drugs and Medications on this site too.